Cochrane Abstracts
Vasodilators for primary Raynaud's phenomenon
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Vasodilators for Primary Raynaud's Phenomenon." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436050/all/Vasodilators_for_primary_Raynaud's_phenomenon.
Vasodilators for primary Raynaud's phenomenon. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436050/all/Vasodilators_for_primary_Raynaud's_phenomenon. Accessed December 8, 2024.
Vasodilators for primary Raynaud's phenomenon. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436050/all/Vasodilators_for_primary_Raynaud's_phenomenon
Vasodilators for Primary Raynaud's Phenomenon [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436050/all/Vasodilators_for_primary_Raynaud's_phenomenon.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Vasodilators for primary Raynaud's phenomenon
ID - 436050
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436050/all/Vasodilators_for_primary_Raynaud's_phenomenon
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
